Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis
Rosita van den Puttelaar(Erasmus MC), Reinier G.S. Meester(Erasmus MC), Iris Lansdorp‐Vogelaar, Carolyn M. Rutter(Fred Hutch Cancer Center), Theodore R. Levin(Kaiser Permanente), Ann G. Zauber(Memorial Sloan Kettering Cancer Center), Anne I. Hahn(Memorial Sloan Kettering Cancer Center)
Cited by 29
Related Papers
Current and future colorectal cancer screening strategies
|Nature Reviews Gastroenterology & Hepatology|2022|491
Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations
|Gastroenterology|2017|193
Quality of Life and Symptom Control after Stent Placement or Surgical Palliation of Malignant Colorectal Obstruction
|Journal of the American College of Surgeons|2009|91
Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision
|Gastroenterology|2024|62
Screening in liver disease: Report of an AASLD clinical workshop
|Hepatology|2004|58